669 results on '"Gilbertson, Richard J"'
Search Results
152. Critical Role for the DNA Sensor AIM2 in Stem Cell Proliferation and Cancer
153. An in vivo screen identifies ependymoma oncogenes and tumor-suppressor genes
154. Cross-Species Genomics Identifies TAF12, NFYC, and RAD54L as Choroid Plexus Carcinoma Oncogenes
155. Molecular Characterization of Choroid Plexus Tumors Reveals Novel Clinically Relevant Subgroups
156. Molecular Insights into Pediatric Brain Tumors Have the Potential to Transform Therapy
157. Abstract IA18: Mapping cancer origins
158. Abstract 4645: Clofarabine, a potent anticancer compound with limited penetration in an orthotopic murine model of ependymoma
159. Abstract 3111: Identification of genes that frequently exhibit copy number alterations in pediatric ependymomas
160. Abstract LB-63: Cell ground state dictates cancer susceptibility across organs
161. The G protein α subunit Gαs is a tumor suppressor in Sonic hedgehog−driven medulloblastoma
162. The landscape of somatic mutations in epigenetic regulators across 1,000 paediatric cancer genomes
163. Erratum: Corrigendum: C11orf95–RELA fusions drive oncogenic NF-κB signalling in ependymoma
164. Driving Glioblastoma to Drink
165. A De NovoMouse Model of C11orf95-RELA Fusion-Driven Ependymoma Identifies Driver Functions in Addition to NF-κB
166. Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas—a Pediatric Brain Tumor Consortium study
167. Dual and opposing roles of primary cilia in medulloblastoma development.
168. Phase I Study of Vismodegib in Children with Recurrent or Refractory Medulloblastoma: A Pediatric Brain Tumor Consortium Study
169. Abstract PR11: Medulloblastoma-associated mutations in the DEAD box RNA helicase DDX3X impair protein translation
170. A prospective phase II study to determine the efficacy of GDC 0449 (vismodegib) in adults with recurrent medulloblastoma (MB): A Pediatric Brain Tumor Consortium study (PBTC 25B).
171. Medulloblastomics: the end of the beginning
172. Pten deletion causes mTorc1-dependent ectopic neuroblast differentiation without causing uniform migration defects
173. Use of whole genome sequencing to identify novel mutations in distinct subgroups of medulloblastoma.
174. WNT signaling increases proliferation and impairs differentiation of stem cells in the developing cerebellum
175. Abstract 2479: TP53 status as a marker of recurrence and survival in choroid plexus carcinomas
176. Abstract PL02-03: Genomic mapping of cancer origins
177. Abstract SY10-03: Cell of origin in pediatric medulloblastomas
178. Abstract 3002: Identification of frequently altered protein networks in ependymomas
179. Copy Number Gain of 1q25 Predicts Poor Progression-Free Survival for Pediatric Intracranial Ependymomas and Enables Patient Risk Stratification: A Prospective European Clinical Trial Cohort Analysis on Behalf of the Children's Cancer Leukaemia Group (CCLG), Société Française d'Oncologie Pédiatrique (SFOP), and International Society for Pediatric Oncology (SIOP)
180. Abstract 1434: A mouse model of the most aggressive subgroup of human medulloblastoma
181. Molecular subgroups of medulloblastoma: the current consensus
182. Finding the Perfect Partner for Medulloblastoma Prognostication
183. Developing treatment strategies for rare cancers
184. Phase I Trial of MK-0752 in Children With Refractory CNS Malignancies: A Pediatric Brain Tumor Consortium Study
185. Phase I Study of Temsirolimus in Pediatric Patients With Recurrent/Refractory Solid Tumors
186. TP53 Mutations in Favorable-Risk Wnt/Wingless-Subtype Medulloblastomas
187. Integrative Genomic Analysis of Medulloblastoma Identifies a Molecular Subgroup That Drives Poor Clinical Outcome
188. Abstract 3442: TP53 mutations in favorable risk WNT subtype medulloblastomas
189. Abstract 3444: Enforced expression of MycN and C-Myc induces different medulloblastoma subtypes
190. Abstract 3449: Epigenomics identifies conserved DNA methylation events associated with medulloblastoma development in humans and mice
191. Abstract 4759: Integrated in vitro and in vivo screening of tumor and normal neural stem cells identifies potential new treatments of ependymoma
192. Mapping Cancer Origins
193. Abstract 3448: Subtypes of medulloblastoma have distinct developmental origins
194. Rapid Diagnosis of Medulloblastoma Molecular Subgroups
195. A phase I and biology study of gefitinib and radiation in children with newly diagnosed brain stem gliomas or supratentorial malignant gliomas
196. Phase I Study of Vandetanib During and After Radiotherapy in Children With Diffuse Intrinsic Pontine Glioma
197. Phase I Trial of Lapatinib in Children With Refractory CNS Malignancies: A Pediatric Brain Tumor Consortium Study
198. Pediatric Phase I Trial and Pharmacokinetic Study of Vorinostat: A Children's Oncology Group Phase I Consortium Report
199. Lack of Efficacy of Bevacizumab Plus Irinotecan in Children With Recurrent Malignant Glioma and Diffuse Brainstem Glioma: A Pediatric Brain Tumor Consortium Study
200. Defining future directions in spinal cord tumor research
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.